Encephalitis, Tick-Borne

Fever After Tick Bite Study

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults